Epstein-Barr virus (EBV) has the ability to promote cell cycle progression following the initial infection of primary resting B-lymphocytes and to cause cell cycle arrest at the onset of the viral replicative cycle. Various mechanisms have been proposed for the proliferative effects, including the up-regulation of cyclin D2 by the viral EBNA-2 and EBNA-LP proteins, direct binding of EBNA3C to the retinoblastoma protein (pRb), and down-regulation of the p16 INK4A tumour suppressor by the viral LMP1 product. To try to gain insight into the relative importance of these mechanisms, the ability of EBV to immortalize lymphocytes from an individual who is genetically deficient for p16 INK4A was examined. From detailed analyses of the resultant lymphoblastoid cell lines it is concluded that p16 INK4A status has little bearing on EBV's ability to manipulate the cell cycle machinery and a model to accommodate the previously proposed routes taken by EBV to bypass the restriction point is presented.
DNA viruses use a variety of strategies to facilitate the replication of their genomes but a common theme is to encode viral proteins that alter host cell proliferation. Among the well-characterized examples are proteins such as simian virus 40 T-antigen, human papillomavirus (HPV) E6 and adenovirus E1A, which override the G 1 phase control point at least in part through a direct interaction with the retinoblastoma gene product (pRb) (Classon & Harlow, 2002; Jansen-Durr, 1996) . However, disabling pRb inevitably results in the activation of the p53 pathway via E2F-mediated induction of p14 ARF . The same viruses therefore specify additional proteins to disarm the p53-dependent defences (Classon & Harlow, 2002; Jansen-Durr, 1996 ). An unusual locus specifies two quite different proteins by translating a shared second exon in different reading frames resulting in the translation of both p14 ARF and a second product p16
INK4A (Chin et al., 1998; Serrano et al., 1993). p16 INK4A is an inhibitor of the cyclin D-dependent kinases, Cdk4 and Cdk6, which normally initiate the phosphorylation and functional inactivation of pRb (Chin et al., 1998; Palmero & Peters, 1996; Ruas & Peters, 1998) . Thus, both products encoded by this locus have the ability to cause cell cycle arrest; in the case of p16
INK4A by preventing the phosphorylation of pRb and in the case of p14 ARF by blocking the Mdm2-mediated destruction of p53, thereby inducing expression of the p21 CIP1 Cdk inhibitor (Bringold & Serrano, 2000; Chin et al., 1998) . Although its functional properties suggest that p16
INK4A could play a role in the G 1 cell cycle control point, upstream of pRb, it is a relatively stable protein whose levels do not fluctuate significantly during the cell cycle. Indeed, the most dramatic changes in p16
INK4A abundance occur when primary cells undergo a senescence-like arrest in response to stress or as a consequence of telomere erosion (Alcorta et al., 1996; Hara et al., 1996; Loughran et al., 1996; Palmero et al., 1997; Reznikoff et al., 1996) .
The human gammaherpesvirus Epstein-Barr virus (EBV) has the ability to promote cell cycle progression following the initial infection of primary resting B-lymphocytes and to cause cell cycle arrest at the onset of the viral replicative cycle (Flemington, 2001; Sinclair, 2003; Sinclair et al., 1998) . It is therefore clear that EBV must impinge on the function of pRb at two crucial stages of its life-cycle. In considering how EBV manipulates the host cell cycle machinery, it is important to stress that it has no direct equivalent of proteins such as T-antigen or HPV E6 and E7 , although it has been shown that one viral gene product, EBNA3C, can interact directly with pRb and confer resistance to p16
INK4A overexpression in rodent fibroblasts (Parker et al., 1996) . The relevance of this interaction in virus-infected cells remains unproven, however. EBV infection of primary B-lymphocytes has been shown to cause a dramatic up-regulation of cyclin D2 (Kempkes et al., 1995; Sinclair et al., 1994) , which is attributable to the combined actions of two viral genes EBNA-2 and EBNA-LP (Sinclair et al., 1994) . A likely outcome will be the activation of Cdk4 and Cdk6 leading to hyperphosphorylation of pRb, as is observed in these cells (Cannell et al., 1996) . Finally, there is compelling evidence that the viral LMP1 protein can down-regulate the expression of p16 INK4A in primary human fibroblasts (Yang et al., 2000) . This occurs in part through effects on the localization of critical transcription factors (Ohtani et al., 2003) . However, at present it remains uncertain whether any of these three routes are sufficient to explain the ability of EBV to manipulate the host cell cycle in infected cells.
To try to gain further insight into these possibilities, we instigated a study on B-lymphocytes from an individual who is effectively p16
INK4A deficient. The individual is homozygous for a 19 bp germline deletion in the INK4A/ ARF locus (Gruis et al., 1995) . As described in detail elsewhere and illustrated in Fig. 1 , the associated frameshift results in the production of two chimaeric proteins: p14/p16, in which the amino-terminal 88 residues of p14 ARF are fused to the last 76 residues of p16 INK4A , and p16/X, comprising the first 74 residues of p16 INK4A followed by 64 amino acids specified by the +1 reading frame (Brookes et al., 2002) . Detailed in vitro and in vivo analyses indicate that neither protein shows any residual INK4A-associated activity whereas the p14/p16 product retains all the known functions of p14 ARF (Brookes et al., 2002) .
Primary B-lymphocytes were isolated from peripheral blood after fractionation of mononuclear cells using a density gradient and positive selection with anti-CD19 coated paramagnetic beads [as described in (Sinclair & Farrell, 1995a, b; Sinclair et al., 1994) ]. Subsequently, the cells were infected with the B95-8 strain of EBV (Baer et al., (Koh et al., 1995) or carboxy-terminal halves of the protein (Lukas et al., 1995; Parry et al., 1995) (Fig. 1B) . Moreover, in normal LCLs p16
INK4A forms a complex with Cdk6 that can be co-precipitated, as predicted for a normally functional INK4 protein (data not shown). L1 and L2 cells only express the p14/p16 fusion protein, detected using the DCS50 monoclonal antibody that recognizes the carboxy terminus of p16
INK4A . This protein is incapable of associating with Cdk4 and Cdk6 (Brookes et al., 2002) . As described elsewhere, the p16/X fusion protein, which would also be encoded by the L1 and L2 cells, appears to be inherently unstable and difficult to visualize (Brookes et al., 2002) . No gross changes to the phosphorylation of pRB were observed, as exemplified by staining with antibodies that recognize total pRb or pRb specifically phosphorylated on serine-780 or serine-807 plus serine-811 (Fig. 1B) .
The phenotypes of the four LCLs were then compared using FACS analysis (Fig. 2) . All displayed the characteristic phenotype for LCLs (Rickinson, 2002) (B) Each cell line was diluted to 3610 5 cells ml "1 and the cell density was recorded over a 10 day period in duplicate; the standard deviation is shown as the error bar. (C) Cells were fixed with 80 % ethanol, stained with propidium iodide as described previously (Cannell et al., 1998) and their DNA content analysed by FACS in duplicate.
The establishment of the LCLs allowed us to undertake an analysis of their cell cycle characteristics. All four cell lines proliferated in an equivalent manner in normal growth conditions (10 % FCS), reaching a similar saturation density (Fig. 2B ) and FACS analysis of propidium iodide-stained cells revealed an equivalent cell cycle profile (Fig. 2C) . Thus, the proliferative capability and cell cycle profile of the LCLs was unaffected by the loss of p16
INK4A .
Since apoptosis is often preceded by cell cycle arrest (Andoh, 2000; King & Cidlowski, 1998; Meikrantz & Schlegel, 1995; Wang et al., 2000) , we questioned whether p16 INK4A status resulted in differences in the potential of the LCLs to survive in response to exposure to the proapoptotic agent anti-FAS (Fig. 3) . Early stages in apoptosis were detected by measuring caspase-3 activity (Fig. 3A ) (Frost & Sinclair, 2000) and also by assaying for the cleavage Fig. 3 . The propensity of the N and L LCLs to undergo apoptosis was assessed. (A) FAS was ligated on L and N cells in duplicate using an anti-FAS antibody. Extracts were prepared at the indicated times and their ability to cleave the caspase-3 substrate DEVD-AMC was determined as described previously (Frost & Sinclair, 2000) . (B) Total protein extracts were prepared, fractionated on SDS-PAGE gels and the status of PARP determined by Western blot analysis as described previously (Frost & Sinclair, 2000) . The dashed arrow represents the p85 cleavage product of PARP and the solid line the fulllength protein. (C) The number of viable cells was determined in triplicate after anti-FAS addition and is plotted on the y-axis with the standard deviation shown as the error bar.
and subsequent degradation of PARP (Fig. 3B) (Frost & Sinclair, 2000) ; both were altered with similar kinetics in the L and N cells. Furthermore, cell survival (Fig. 3C ) and DNA fragmentation (data not shown) were assayed to measure late stages of apoptosis. No differences were found in the response of the L and N cells to anti-FAS, or to two other pro-apoptotic agents, staurosporin or etoposide (data not shown). This clearly demonstrates that p16 INK4A status has no effect on the propensity of LCLs to undergo apoptosis.
We then investigated whether the balance between latency and virus replication was altered in the L and N cells. The expression of an early marker of viral lytic cycle, Zta, was assessed by both Western blot analysis (Fig. 4A ) and FACS analysis (Fig. 4B) . The expression of Zta was equivalent in both L and N cells (mean fluorescence intensity of 3?7 for N cells and 3?0 for L cells), with a similarly small proportion of positive cells. This suggests that p16 status does not influence the ability of cells to enter the early stages of the viral lytic cycle. , since it is still detectable in LCLs. (ii) In addition, expression of cyclin D2, Cdk4 and Cdk6 are upregulated by EBV and so could alter the stoichiometry between cyclin-bound and p16
INK4A -bound forms of Cdk4 and Cdk6 within the cells. (iii) In addition, the function of pRb could be directly modulated by association with EBNA3C. This trio of routes available to EBV to modulate the function of the restriction point could be required allow EBV to regulate the proliferation of infected cells from diverse lineages.
